XIAP as a regulator of inflammatory cell death: the TNF and RIP3 angle

Por Yabal, Monica, Jost, Philipp J
Publicado no Mol Cell Oncol (2014)

Necroinflammation emerges as a key regulator of hematopoiesis in health and disease

Por Jost, Philipp J., Höckendorf, Ulrike
Publicado no Cell Death Differ (2018)

Regulation of Cell Death and Immunity by XIAP

Por Jost, Philipp J., Vucic, Domagoj
Publicado no Cold Spring Harb Perspect Biol (2020)

The many roles of FAS receptor signaling in the immune system

Por Strasser, Andreas, Jost, Philipp J, Nagata, Shigekazu
Publicado em 2009

Killing AML: RIPK3 leads the way

Por Höckendorf, Ulrike, Yabal, Monica, Jost, Philipp J.
Publicado no Cell Cycle (2016)

RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICs

Por Höckendorf, Ulrike, Yabal, Monica, Jost, Philipp J.
Publicado no Oncotarget (2016)

Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft

Por Moog, Philipp, Jost, Philipp J., Büttner-Herold, Maike
Publicado no BMC Nephrol (2018)

Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils

Por Wicki, Simone, Gurzeler, Ursina, Wei-Lynn Wong, W, Jost, Philipp J, Bachmann, Daniel, Kaufmann, Thomas
Publicado no Cell Death Dis (2016)

The Acute Transcriptomic and Proteomic Response of HC-04 Hepatoma Cells to Hepatocyte Growth Factor and its Implications for Plasmodium falciparum Sporozoite Invasion

Por Tao, Dingyin, King, Jonas G., Tweedell, Rebecca E., Jost, Philipp J., Boddey, Justin A., Dinglasan, Rhoel R.
Publicado em 2014

Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature

Por Schweneker, Katrin, Clemm, Christoph, Brügel, Melanie, Souvatzoglou, Michael, Hermisson, Mirjam, Schmidt-Graf, Friederike, Zimmer, Claus, Peschel, Christian, Jost, Philipp J
Publicado no Exp Hematol Oncol (2014)

Mcl-1 is Essential for Germinal Center Formation and B cell Memory

Por Vikstrom, Ingela, Carotta, Sebastian, Lüthje, Katja, Peperzak, Victor, Jost, Philipp J., Glaser, Stefan, Busslinger, Meinrad, Bouillet, Philippe, Strasser, Andreas, Nutt, Stephen L., Tarlinton, David M.
Publicado em 2010

Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling

Por Damgaard, Rune Busk, Fiil, Berthe Katrine, Speckmann, Carsten, Yabal, Monica, zur Stadt, Udo, Bekker-Jensen, Simon, Jost, Philipp J, Ehl, Stephan, Mailand, Niels, Gyrd-Hansen, Mads
Publicado em 2013

CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling

Por Hrdinka, Matous, Fiil, Berthe Katrine, Zucca, Mattia, Leske, Derek, Bagola, Katrin, Yabal, Monica, Elliott, Paul R., Damgaard, Rune Busk, Komander, David, Jost, Philipp J., Gyrd-Hansen, Mads
Publicado no Cell Rep (2016)

A step towards valid detection and quantification of lung cancer volume in experimental mice with contrast agent-based X-ray microtomography

Por Bidola, Pidassa, Martins de Souza e Silva, Juliana, Achterhold, Klaus, Munkhbaatar, Enkhtsetseg, Jost, Philipp J., Meinhardt, Anna-Lena, Taphorn, Kirsten, Zdora, Marie-Christine, Pfeiffer, Franz, Herzen, Julia
Publicado no Sci Rep (2019)

XIAP acts as a switch between type I and type II FAS-induced apoptosis signalling

Por Jost, Philipp J., Grabow, Stephanie, Gray, Daniel, McKenzie, Mark D., Nachbur, Ueli, Huang, David C.S., Bouillet, Philippe, Thomas, Helen E., Borner, Christoph, Silke, John, Strasser, Andreas, Kaufmann, Thomas
Publicado em 2009

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM

Por Huemer, Florian, Melchardt, Thomas, Jansko, Bettina, Wahida, Adam, Jilg, Stefanie, Jost, Philipp J., Klieser, Eckhard, Steiger, Katja, Magnes, Teresa, Pleyer, Lisa, Greil‐Ressler, Sigrun, Rass, Christof, Greil, Richard, Egle, Alexander
Publicado no Eur J Haematol (2019)

Fatal Hepatitis Mediated by TNFα Requires Caspase-8 and Involves the BH3-only Proteins Bid and Bim

Por Kaufmann, Thomas, Jost, Philipp J, Pellegrini, Marc, Puthalakath, Hamsa, Gugasyan, Raffi, Gerondakis, Steve, Cretney, Erika, Smyth, Mark J, Silke, John, Hakem, Razq, Bouillet, Philippe, Mak, Tak W, Dixit, Vishva M, Strasser, Andreas
Publicado em 2009

TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP

Por Knop, Janin, Spilgies, Lisanne M., Rufli, Stefanie, Reinhart, Ramona, Vasilikos, Lazaros, Yabal, Monica, Owsley, Erika, Jost, Philipp J., Marsh, Rebecca A., Wajant, Harald, Robinson, Mark D., Kaufmann, Thomas, Wong, W. Wei-Lynn
Publicado no Cell Death Dis (2019)

Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP

Por Knop, Janin, Spilgies, Lisanne M., Rufli, Stefanie, Reinhart, Ramona, Vasilikos, Lazaros, Yabal, Monica, Owsley, Erika, Jost, Philipp J., Marsh, Rebecca A., Wajant, Harald, Robinson, Mark D., Kaufmann, Thomas, Wong, W. Wei-Lynn
Publicado no Cell Death Dis (2020)

Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile

Por Reidel, Veronika, Kauschinger, Johanna, Hauch, Richard T., Müller-Thomas, Catharina, Nadarajah, Niroshan, Burgkart, Rainer, Schmidt, Burkhard, Hempel, Dirk, Jacob, Anne, Slotta-Huspenina, Julia, Höckendorf, Ulrike, Peschel, Christian, Kern, Wolfgang, Haferlach, Torsten, Götze, Katharina S., Jilg, Stefanie, Jost, Philipp J.
Publicado no Oncotarget (2018)